Cold plasma treatment for chronic wounds in adults
Official title: Study of Tolerance to the Application of Cold Plasma in the Treatment of Chronic Wounds
Run by Centre Hospitalier Régional d'Orléans · NCT07564739 · Data updated 2026-11-12
This study tests whether cold plasma applied with helium and dressings infused with plasma-induced ions can help healing in adults with chronic leg or other vascular wounds.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Centre Hospitalier Régional d'Orléans Academic / other |
| Locations | 1 site (Orléans) |
| Status | Recruiting |
| Started | May 12, 2026 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | May 15, 2026 |
| Trial ID | NCT07564739 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older with a chronic wound or ulcer (5–100 cm²) of arterial or venous origin, present for more than 4 weeks, with limited necrosis.
✕Probably not a fit
Patients outside the wound size criteria, with recent revascularization needs, severe organ dysfunction, or other exclusion factors may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial explores a non-pharmacologic approach using helium-based cold plasma applied to chronic wounds at different durations, plus dressings with plasma-induced ions. Participants are adults with slow-healing wounds of arterial or venous origin that have persisted for over four weeks and meet size and health criteria. The study aims to observe wound healing progress and safety in an interventional setting without a traditional drug component. Recruitment is centered at a single French hospital site, with eligibility based on wound type, size, and overall health status. Outcomes will inform whether this plasma-based therapy could become a practical option for chronic wound management.
Why it matters
Potential benefit: If successful, patients could experience faster wound healing and potentially improved quality of life.
How similar studies have gone: Past studies in related plasma-based approaches show potential but this exact method is relatively novel in chronic wounds.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Men or women. 2. Aged 18 years or older. 3. Chronic wound or ulceration. 4. Wound measuring 5 to 100 cm² of arterial or venous origin. 5. Evolution \> 4 weeks. 6. With less than 30% necrosis. 7. Able to give informed written consent. 8. Blood pregnancy test for women of childbearing age. Exclusion Criteria: 1. Tumor wounds 2. Dialysis 3. Patients requiring surgical revascularization 4. Severe heart failure (NYHA III-IV) or acute myocardial infarction. 5. Wounds or ulcers located less than 10 cm from the patient's airways and respiratory tract 6. Severe renal failure defined as creatinine clearance \<20 mL/min calculated according to the MDRD 7. Patients with severe hepatic impairment (class C) according to the Child Pugh score 8. Unstable liver disease (defined by the presence of ascites, encephalopathy, coagulopathy, hypoalbuminemia, esophageal or gastric varices, or persistent jaundice), cirrhosis, known biliary abnormality. 9. Active malignant tumor 10. Patients who, in the investigator's opinion, are at significant risk of suicide 11. Any pre-existing physical or mental condition that may interfere with the patient's ability to comply with the administration schedule and/or protocol assessments, or that may compromise the patient's safety. 12. Persons covered by Articles L.1121-5 to L.1121-8 and L.1122-1-2 of the Public Health Code (including minors and protected adults) 13. Protected person (under guardianship or curatorship) 14. Person under judicial protection 15. Persons deprived of their liberty 16. Persons not affiliated with a social security system 17. Women who are pregnant or breastfeeding, or who plan to become pregnant or breastfeed during the study. 18. Patients participating in another clinical trial evaluating a treatment 19. Allergy to the dressings used in the trial
Where it's running
-
Centre Hospitalier Universitaire d'Orléans, France
Orléans, France Recruiting
Study contacts
- Study coordinator: Thierry PRAZUCK, PH
- Email: thierry.prazuck@chu-orleans.fr
- Phone: +332 38 51 43 61
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multicenter test of several CAMP products plus standard care for nonhealing pressure ulcers
This trial tests five different CAMP products added to standard care to see if they help heal nonhealing pressure ulcers in adults.
-
Miro3D tissue scaffold for complex soft-tissue wounds and pressure ulcers
This trial will test whether adding the Miro3D tissue scaffold to usual wound care helps adults with complex soft-tissue wounds or chronic pressure ulcers heal faster over 12 weeks.
-
Diaphragm function after an interscalene block with liposomal bupivacaine
This study tests whether liposomal bupivacaine used with an interscalene block affects diaphragmatic function in adults having upper limb surgery.
-
Cyanoacrylate glue versus collagen sponge for healing palatal donor wounds
This test compares cyanoacrylate glue (PeriAcryl) and collagen sponge to see which helps adult patients' palatal donor sites heal faster and feel more comfortable after a free gingival graft.
-
Amnion grafts for hard-to-heal diabetic foot and venous leg ulcers
This study will test whether two types of amnion grafts, added to standard wound care, help hard-to-heal diabetic foot and venous leg ulcers heal better.
-
Using Negative Pressure Therapy to Prevent Infections in Surgical Wounds
This study is testing if using Negative Pressure Therapy can help prevent infections in surgical wounds for people who have had laparotomy surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.